Microaxial flow pump in cardiogenic shock: a retrospective cohort study on outcomes and feasibility as a bridge to LVAD implantation
This study suggests that Impella CP support in cardiogenic shock can be safe and feasible, serving as a bridge-to-recovery or a bridge-to-decision for LVAD implantation candidacy. However, Impella CP in the Impella-limited group is not useful. This underscores the importance of precise patient selection in cardiogenic shock therapy escalation.
Authors
- Tim P. van de Hoef (ORCID: https://orcid.org/0000-0003-0682-0619)
- Pim van der Harst (ORCID: https://orcid.org/0000-0002-2713-686X)
- Linda van Laake
- Joep M. Droogh (ORCID: https://orcid.org/0000-0001-9626-2248)
- Adriaan O. Kraaijeveld (ORCID: https://orcid.org/0000-0001-5136-5606)
- Gabija Pundziūtė (ORCID: https://orcid.org/0000-0002-7558-7331)
- Kevin Damman (ORCID: https://orcid.org/0000-0003-0190-2228)
- Jeannine A. J. M. Hermens (ORCID: https://orcid.org/0000-0001-7882-9298)
- Einar A. Hart (ORCID: https://orcid.org/0000-0003-4905-036X)
- Jan-Willem Balder
- Erik Lipšic (ORCID: https://orcid.org/0000-0002-7407-3064)
- Michiel Voskuil (ORCID: https://orcid.org/0000-0003-1789-8462)
- Mariusz K. Szymanski (ORCID: https://orcid.org/0000-0003-3110-0226)
- Michael G. Dickinson (ORCID: https://orcid.org/0000-0003-1980-1919)
- F. Ramjankhan
Institutions
- University Medical Center Groningen (NL)
- University Medical Center Utrecht (NL)
Publication Details
- Journal
- Netherlands Heart Journal
- Published
- 2025-07-01
- DOI
- https://doi.org/10.1007/s12471-025-01963-2
- Citations
- 1
- Primary Topic
- Mechanical Circulatory Support Devices
- Type
- article
- Field-Weighted Citation Impact
- 0.67